How Much Will I Get From the Johnson & Johnson Talcum Powder $8 Billion Settlement?

Based on the $44 total fund and estimated claimant participation, the per-person payout for the Johnson & Johnson Talcum Powder $8 Billion Settlement is estimated at Up to $44. However, actual payouts depend on the total number of valid claims filed and final court approval.

You may be eligible to file a claim if you: Were diagnosed with ovarian cancer, mesothelioma, or another asbestos-related illness Were diagnosed with ovarian cancer, mesothelioma, or another asbestos-related illness Used Johnson’s® Baby Powder, Shower to Shower®, or another talc-based product regularly Used Johnson’s® Baby Powder, Shower to Shower®, or another talc-based product regularly Are filing on behalf of a loved one who passed away due to talcum powder-related cancer Are filing on behalf of a loved one who passed away due to talcum powder-related cancer Submit a valid and timely claim form before the legal deadline Submit a valid and timely claim form before the legal deadline

No proof required! The Johnson & Johnson Talcum Powder $8 Billion Settlement is a no-proof settlement. You simply need to confirm your eligibility by answering a few basic questions. No receipts or documentation needed.

No filing deadline has been announced yet for the Johnson & Johnson Talcum Powder $8 Billion Settlement. Check back regularly or enable notifications to be alerted when a deadline is set.

Class action settlement payouts are calculated by dividing the total settlement fund by the number of valid claims submitted. Our estimates are based on historical participation rates for similar settlements. Actual amounts are determined by the settlement administrator after the filing deadline.

After the filing deadline passes, the settlement administrator reviews all claims, resolves disputes, and receives final court approval. This process typically takes 3–18 months. Once approved, payments are distributed via check, PayPal, Venmo, or gift cards depending on the settlement terms.